Suppr超能文献

肺癌筛查标准与心肺合并症

Lung Cancer Screening Criteria and Cardiopulmonary Comorbidities.

作者信息

Pu Chan Yeu, Lusk Christine M, Neslund-Dudas Christine, Gadgeel Shirish, Soubani Ayman O, Schwartz Ann G

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, Michigan.

Karmanos Cancer Institute, Detroit, Michigan.

出版信息

JTO Clin Res Rep. 2022 Jul 4;3(8):100377. doi: 10.1016/j.jtocrr.2022.100377. eCollection 2022 Aug.

Abstract

INTRODUCTION

Lung cancer screening criteria should select candidates with minimal cardiopulmonary comorbidities who are fit for curative lung cancer resection.

METHODS

We retrospectively analyzed 728 patients with lung cancer for screening eligibility using the U.S. Preventive Services Task Force (USPSTF) 2013 criteria (n = 370). If ineligible for screening, they were further assessed for eligibility using the USPSTF 2021 (n = 121) and National Comprehensive Cancer Network group 2 (NCCN gp 2) (n = 155). Comparisons of cardiopulmonary comorbidities between patients selected by the different lung cancer screening criteria were performed. Excluding missing data, a similar comparison was done between USPSTF 2013 (n = 283) and PLCOm2012 (risk threshold ≥1.51%) (n = 118).

RESULTS

Patients eligible for USPSTF 2021 and NCCN gp 2 had lower rates of airflow obstruction (forced expiratory volume in 1 s [FEV1]/forced vital capacity <0.7) compared with those in USPSTF 2013 (55.4% and 56.8% versus 70.5%). Both USPSTF 2021 and NCCN gp 2 groups had less severe airflow obstruction; only 11.6% and 12.9% of patients, respectively, had percent-predicted FEV1 less than 50% versus 20.3% in the USPSTF 2013 group. Comparing USPSTF 2013 and PLCOm2012 revealed no significant differences in age or the rate of airflow obstruction ( = 0.06 and = 0.09 respectively). Nevertheless, rates of percent-predicted FEV1 less than 50% and diffusing capacity of the lungs for carbon monoxide less than 50% were lower in the PLCOm2012 group compared with those in the USPSTF 2013 group (22.3% versus 10.2% and 32.6% versus 20.0%), respectively.

CONCLUSIONS

The USPSTF 2021 qualifies an additional group of screening candidates who are healthier with better lung reserve, translating to better surgical candidacy but potentially more overdiagnosis. The PLCOm2012, with its better accuracy in selecting patients at risk of cancer, selects an older group with chronic obstructive pulmonary disease but with good lung reserve and potentially less overdiagnosis.

摘要

引言

肺癌筛查标准应筛选出心肺合并症最少且适合进行肺癌根治性切除术的患者。

方法

我们回顾性分析了728例肺癌患者,使用美国预防服务工作组(USPSTF)2013年标准(n = 370)评估其筛查资格。如果不符合筛查条件,则使用USPSTF 2021年标准(n = 121)和美国国立综合癌症网络第2组(NCCN gp 2)标准(n = 155)进一步评估其资格。对不同肺癌筛查标准所选择患者的心肺合并症进行了比较。排除缺失数据后,对USPSTF 2013年标准组(n = 283)和PLCOm2012标准组(风险阈值≥1.51%)(n = 118)进行了类似比较。

结果

符合USPSTF 2021年标准和NCCN gp 2标准的患者气流阻塞发生率(1秒用力呼气容积[FEV1]/用力肺活量<0.7)低于符合USPSTF 2013年标准的患者(分别为55.4%和56.8%对70.5%)。USPSTF 2021年标准组和NCCN gp 2标准组的气流阻塞程度均较轻;分别只有11.6%和12.9%的患者预测FEV1百分比低于50%,而USPSTF 2013年标准组为20.3%。比较USPSTF 2013年标准和PLCOm2012标准发现,年龄或气流阻塞发生率无显著差异(分别为P = 0.06和P = 0.09)。然而,PLCOm2012标准组预测FEV1百分比低于50%和肺一氧化碳弥散量低于50%的发生率低于USPSTF 2013年标准组(分别为22.3%对10.2%和32.6%对20.0%)。

结论

USPSTF 2021年标准使另一组筛查候选者符合条件,这些患者更健康,肺储备更好,意味着手术候选资格更好,但可能过度诊断更多。PLCOm2012标准在选择癌症风险患者方面准确性更高,选择的是患有慢性阻塞性肺疾病但肺储备良好且可能过度诊断较少的老年组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db3e/9307937/a46505d7b929/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验